期刊文献+

血清胱抑素C和尿微量白蛋白测定在糖尿病肾病早期的临床价值探讨 被引量:4

The Clinical Value of Serum Cystatin C and Microalbuminuria in Early Diabetic Nephropathy
暂未订购
导出
摘要 目的检测血清胱抑素C(Cystatin,Cys C)和尿微量白蛋白(Microalbuminuria,MAU),评价Cys C和MAU在糖尿病早期肾功能损伤的临床价值。方法收集60例2型糖尿病患者血清和晨尿,分别测定血清Cys C浓度和MAU浓度,与80例健康对照组进行比较。结果患者组与健康对照组的Cys C和MAU均有显著性差异(P<0.01)。结论 Cys C和MAU是临床诊断糖尿病患者肾功能早期损伤的特异而灵敏指标。 Objective Detect serum Cystatin C and urinary albumin, in order to evaluate their clinical value in early diabetic renal injury. Methods To determine Cys C and MAU in 60 patients who have type 2 diabetes,and 80 healthy control group. Results significant difference was observed between patients and healthy people(P〈0.01).Conclusion Cys C and MAU may be clinically utilized as a sensitive and reliability indicator of early diabetes renal dysfunction.
作者 黄光武
出处 《中国医药指南》 2012年第24期399-400,共2页 Guide of China Medicine
关键词 糖尿病肾病 胱抑素C 尿微量白蛋白 早期诊断 Diabetic nephropathy Cystatin Microalbuminuria Early diagnosis
  • 相关文献

参考文献4

二级参考文献6

共引文献226

同被引文献31

  • 1中华医学会糖尿病分会.中国糖尿病防治指南[M].北京:北京大学医院出版社,2004:135.
  • 2Gema F.J,Jos6 L,Vicente B,et al. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy :a Randomized trial [J]. American Journal of Kidney Diseases, 2013,61 (2) :211-218.
  • 3NicoRts RR,Flavio F, Rocio MG,et al. Hematocrit, urea and gender: The Hematocrit, Urea and GEnder formula for prognosing progressive renal failure in diabetic nephropathy[J]. European Journal of Inter- hal Medicine, 2012,23 (3) : 283-286.
  • 4Jun HL,Sang SK,In JK,et al. Clinical implication of plasma and urine YKI..-40,as a proi nflammatory biomarker ,on early stage of nephropa- thy in type 2 diabetic patients[J]. Journal of Diabetes and its Compli- cations, 2012,26 (4) : 308-312.
  • 5Yang WY, Lu JM, Weng JP, et al. Prevalence of Diabetes among Men and Women in China [ J ]. N Engl J Med, 2010,25 (12) : 1 090 - 1 101.
  • 6Abaterussoc, Gambaro G. The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy [ J ]. Treat Endocnnol, 2006,5 (4) : 211 - 222.
  • 7Rodby RA, Rohde RD, Clarke WR, et al. The Irbesartan type diabetic nephropathy trial study design and baseline patient characteristics for the Collaborative Study Group[J]. Nephrol Dial Transplant,2000, 15: 487 - 497.
  • 8胡金梅,张松,张厚兴,邹宇洁.厄贝沙坦治疗糖尿病肾病的疗效观察[J].中国医药导报,2010,7(2):59-60. 被引量:12
  • 9张镇陵.2型糖尿病肾病危险因素分析与护理[J].临床护理杂志,2010,9(4):23-25. 被引量:11
  • 10刘荣.老年糖尿病肾病的护理[J].护士进修杂志,2010,25(18):1691-1693. 被引量:17

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部